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of	 saliva	 per	 day:	 during	 rest	 conditions	most	 of	 this	 liquid	 is	 produced	 by	 the	
submandibular	gland,	while	only	20%	relies	on	the	parotyd	gland.	Instead,	in	case	
of	 the	 presence	 of	 a	 chemycal	 or	 mechanical	 stimulus,	 over	 50%	 of	 saliva	 	 is	
produced	by	the	parotyd	gland.	









Salivary	 production	 is	 regulated	 by	 parasympathetic	 and	 sympathetic	 nervous	
system;	 within	 salivary	 glands,	 primary	 saliva	 is	 produced	 by	 acinar	 cells	
localized	in	the	secretory	area,	then	it	is	passes	through	secretory	ducts	where	it	
is	modified,	and	finally	it	is	poured	in	the	oral	cavity.		The	parotid	gland	and		the	
submandibular	 gland	 have	 a	 single	 duct,	 called	 Stensen’s	 duct	 	 and	Wharton’s	








































the	 presence	 of	 antiviral,	 antibacterial	 and	 antifungal	 substances:	
Immunoglobulins	 A,	 Lysozyme,	 Lactoferrin,	 Histatins,	 Peroxydase,	
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Antimicrobial	peptides	(AMPs,	divided	in	cathelicidin	LL-37,	α-defensins	and	
ß-defensins	 )	 .	 An	 alteration	 in	 their	 composition	 or	 function	may	 explain	
how	 several	 subjects	 are	 more	 predisposed	 to	 infections	 than	 others.	
Besides,	it	has	been	shown	than	AMPs	participate	in	immunomodulation;	so	
an	 alteration	 in	 their	 quantity	 could	 be	 related	 to	 the	 pathogenesis	 of	
several	infective	or	autoimmune	diseases.		
- the	 buffering	 capacity,	 due	 to	 the	 presence	 of	 bicarbonate,	 proteins	 and	
phosphates	
- many	proteins	coming	 from	the	bloodstream	may	be	 found	 in	saliva,	such	
as	Albumins,	Epithelial	Growth	Factor	(EGF),	TGF-α,	TGF-ß	and	Fibroblast	













Its	 constant	 variabilty	 during	 the	 day,	 according	 to	 circadian	 rythm,	makes	 the	
operation	hard.	
Saliva	production	is	influenced	by	indipendent	variables,	which	can	not	be	taken	
under	 control	 during	 collection.	 They	 are:	 age,	 sex,	 body	 weight,	 drugs	
assumption,	glands	dimension	and	general	health.	On	the	other	hand,	dependent	
variables,	which	have	to	be	controlled	during	sampling	are:	chemical	or	physical	
stimulation,	 time	of	 the	day,	 temperature,	 body	position	 and	 light	 exposition.	A	
proper	 collection	 can	 be	 performed	 only	 if	 	 homogeneous	 environmental	
conditions	are	mantained.	
In	 particular	 the	 time	 of	 day	 in	 which	 collection	 is	 done	 repesents	 the	 most	
significant	variable	to	be	considered;	the	mornig	hours	(between	8.00	and	11.00	
a.m.)	should	be	preferred	[1].	
	When	 a	 precise	 time	 is	 established,	 it	 has	 to	 be	 mantained	 in	 order	 to	 better	
compare	 results	 from	 different	 examinations.	 Also	 enviroment	 light	 and	
temperature	must	be	kept	constant.	
	In	 addition,	 eating	 or	 drinking	 during	 90	 minutes	 before	 examination	 is	 not	
reccomended	.	An	appropriate	collection	should	last	about	15	minutes.	























there	 to	 be	 passively	 wet	 by	 saliva	 	 (in	 this	 case	 salivary	 production	 is	
stimulated	by	the	presence	of	a	foreign	body	in	the	mouth).	
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- The	 chewing	 technique:	 A	 small	 piece	 of	 paraffin	 wax	 is	 chewed	 by	 the	
patient	for	5	minutes;	then	saliva	has	to	be	spitted	into	a	test	tube.	
































localized	 in	the	gingival	sulcus	surrounding	teeth	crowns.	 It	 is	produced	 in	very	








It	 cleanses	 material	 from	 the	 sulcus	 and	 contains	 proteins	 useful	 to	 improve	



























































The	 term	 "periodontium"	 usually	 refers	 to	 the	 area	 around	 the	 tooth	 (Peri	 =	
around,	Odontos=	tooth)	whose	main	function	is	to	to	keep	the	tooth	attached	to	
the	tissues	of	the	the	jawbone,	thus	allowing		the	masticatory	function.	
It	 is	a	dynamic	 structure	 that	 is	 involved	 in	a	 continuous,	 longlife,	 transforming	
















of	 food	 during	 chewing)	 formed	 by	 keratinized	 stratified	 squamous	
epithelium,	which	 can	be	 found	on	 the	dorsum	of	 the	 tongue,	 hard	palate	
and	attached	gingiva.				


















In	 coronal	 direction	 it	 ends	 next	 to	 the	 tooth	 surface	with	 the	 gingival	margin,	



















direction	 by	 gingival	 mrgin.	 Free	 gingiva	 also	 includes	 oral	 tissue	 in	 the	
interdental	spaces	called		papilla.	







single	contact	points	 in	correspondence	of	 the	approximal	surfaces.	However	 in	















It	 consists	 of	 cells,	 nerve	 fibers,	 blood	 and	 lymphatic	 vessels,	 inserted	 in	 an	
extracellular	 matrix	 mainly	 formed	 by	 connective	 fibers	 with	 different	
orientation:	
• Alveolar	 crest	 fibers,	 running	 from	 the	 crestal	 portion	 of	 the	 root	 to	 the	
alveolar	ridge	
• Horizontal	fibers,	located	in	the		coronal	portion	of	the	ligament	
• Oblique	 fibers,	 running	 from	 the	 root	 in	 coronal	 direction	 towards	 the	
alveolar	bone	








this	 process	 a	 stabilization	 occurs,	 however	 constant	 remodelling	 (with	
reabsorption	 of	 the	 old	 fibres	 and	 the	 formation	 of	 the	 new	 ones)	 is	 always	
observed.	
The	main	 fibres,	 penetrating	 the	 cement	 on	 one	 side	 and	 alveolar	 bone	 on	 the	




bone	 surface	 and	 cementoblasts	 on	 the	 root	 surface,	 epithelial	 cells	 (Malassez	


































• Fibrillar	 cementum:	 cementum	 with	 a	 matrix	 that	 contains	 well-defined	
type	I	collagen	fibrils	
• Afibrillar	cementum:	cementum	that	has	a	matrix	devoid	of	detectable	type	I	





• Extrinsic	 fiber	 cementum:	 cementum	 containing	 primarily	 extrinsic	 fibers	
(i.e.	 Sharpey's	 fibers	 that	 are	 continuous	 with	 the	 principal	 fibers	 of	 the	




(i.e.	 fibers	 produced	 by	 cementoblasts	 and	 oriented	 parallel	 to	 the	
cementum	 surface).	 It	 is	 located	 predominantly	 in	 areas	where	 repairing	
processes	are	occurring,	after	surface	resorption.	




























The	 bundle	 bone	 is	 peforated	 by	 several	 small	 channels,	 known	 as	 Volkmann	
channels,	through	which	blood	vessels,	lymphatics	and	nerve	fibers	pass	from	the	



















follows:	 Actinobacteria,	 Bacteroidetes,	 Chlamydiae,	 Chloroflexi,	 Euryarchaeota,	
Firmicutes,	 Fusobacteria,	 Proteobacteria,	 Spirochaetes,	 SR1,	 Synergistetes,	
Tenericutes,	and	TM7.	
According	 to	 a	 recent	 study,	 the	 six	 major	 phyla	 (Spirochaetes	 ,	 Fusobacteria,	
Proteobacteria,	Actinobacteria,		Bacteroidetes	and	Firmicutes)	contain	96%	of	the	














This	 complex	 ecosystem	 is	 also	 characterized	 by	 a	 high	 dynamism,	 due	 to	 the	
continuous	 elimination	 and	 introduction	 of	 liquids	 and	 food.	 Although	 a	 rather	
constant	 resident	 bacterial	 population	 is	 present,	 some	 microorganisms	 that	
usually	colonize	other	sites	of	the	host	can	occasionally	be	detected	in	this	area.	





In	 the	 past	 only	 individual	 microorganisms	 were	 considered	 responsible	 for	 a	
specific	disease,	so	they	were	analyzed	in	pure	cultures,	according	to	well-known	











selective	 binding	 of	 salivar	 glycoproteins	immediatly	 after	 a	 tooth	 is	 cleaned	 or	
after	 chewing.	 This	 creates	 the	 necessary	 substrate	 for	 the	 adhesion	 of	 early-
bacterial	 microorganisms.	 These	 first	 ones	 are	 basically	 aerobic	 or	 facultative	
anaerobic	bacteria,	 such	as	 streptococci,	 and	 they	begin	 to	 subtract	oxygen	and	
produce	carbon	dioxide	and	waste	elements,	which	become	food	for	new	bacteria.	
Secondary	colonizers	attach	to	receptors	positioned	on	already	attached	bacteria	











As	 the	 biofilm	 becomes	 structurally	 and	 functionally	 organized	 and	 the	




















Periodontal	 disease	 is	 one	 of	 the	most	 common	 oral	 disease,	 affecting	 globally	
about	half	of	the	adult	population.		It		is	an	infectious	inflammatory	multifactorial	
disease	caused	by	several	bacterial	strains	present	in	dental	plaque.	
In	 physiological	 conditions	 the	 oral	 cavity	 is	 colonized	 by	 a	 huge	 number	 of	
bacteria,	 living	 togheter	 in	 polymicrobial	 communities	 called	 biofilm.	 Although	
early	 theories	 focusing	 on	 identifying	 a	 single	 bacterium	 responsible	 for	 oral	







Among	 oral	 bacteria	 ,	 expecially	 those	 belonging	 to	 "red"	 complex	 (Treponema	
denticola,	 Porphyromonas	 gingivalis,	 and	 Bacteroides	 forsythus)	 and	 "orange"	
complex	 (Prevotella	 intermedia,	 Prevotella	 nigrescens,	 Peptostreptococcus	
micros,	 F.	 nucleatum	 subspecies,	 Eubacterium	 nodatum,	 Streptococcus	
constellatus,	 and	 three	 Campylobacter	 species)	 are	 considered	 dangerous	 in	
development	of	the	disease.	
Periodontitis	 is	 the	 major	 cause	 of	 tooth	 loss	 in	 the	 adult	 population	 of	
industrialized	countries	with	esthetic	consequences	and	damages	in	masticatory	
and	phonatory	functions.	The	prevalence	of	periodontal	disease	in	the	population	









A	 	 	 	 	 	 	 	 	 B	
	
Fig.	 22	 A:	 Periodotal	 pocket	 and	 healty	 tissue;	 B:	 Gingivitis-periodontitis	
progression	
	
The	 classification	 of	 periodontal	 diseases	 proposed	 in	 1993	 by	 the	 European	












































































































Differential	 diagnosis	 must	 be	 performed	 with	 other	 causes	 of	 hypermobility,	
such	 as	 occlusal	 trauma,	 reduction	 of	 supporting	 bone,	 orthodontic	 treatment.	
Dental	 mobility	 is	 assested	 by	 tapping	 the	 thooth	 between	 two	 instrument	
















and	 the	 gum.	 It	 allows	 the	 detection	 of	 	 periodontal	 pockets,	 level	 of	 clinical	
attachment,	 involvement	 of	 forcations,	 presence	 of	 subgingival	 tartar	 and/or	
incongruous	 restorations.	 Presence	 of	 bleeding	 during	 dental	 probing	 is	 an	
important	risk	factor	for	periodontitis	progression.	
The	PSR	system	is	a	clinical	method	created	to	evaluate	the	severity	of	periodontal	
disease	 by	 introducing	 a	 specific	 calibrated	dental	 probe	 into	 gingival	 sulcus	 of	
each	 tooth	 (Six	 measurements	 for	 each	 tooth	 are	 obtained	 along	 the	 entire	






















































































In	 colorectal	 cancer	 malignant	 transformation	 is	 generally	 slow	 (it	 takes	 more	
than	 10	 years)	 and	 is	 characterized	 by	 parallel	 changes	 in	 the	 molecular	 and	
histological	side.	
















Familial	 Adenomatous	 Polyposis	 (FAP)	 and	 its	 variants	 (Gardner's	 syndrome,	
Turcot's	 syndrome	 and	 Zanca's	 syndrome)	 have	 been	 related	 to	 a	 higher	
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probability	of	developing	colorectal	cancer;	according	to	some	authors	about	2%–




multiple	 (usually	 more	 than	 100)	 colorectal	 adenomatous	 polyps.	 Incidence	 is	
approximately	 1	 in	 10,000	 cases	 and	 it	 is	 responsible	 for	 1%	 of	 all	 colorectal	
cancers	in	the	United	States	[25].		
In	 this	 condition,	 specific	 mutations	 occur	 in	 the	 APC	 gene,	 located	 on	
chromosome	5.	It	is	precisely	this	gene	that	is	thought	to	play	an	important	role	in	












A	 different	 genetic	 condition	 not	 related	 with	 intestinal	 polyposis	 is	 Lynch	
Syndrome	or		Hereditary	Nonpolyposis	Colorectal	Cancer	(HNPCC),	an	autosomal	
dominant	genetic	disease,	showing	a	50%–70%	lifetime	risk	of	colorectal	cancer,	













Peutz-Jeghers	 syndrome	 is	 a	 less	 less	 frequent	 condition	 (incidence	 is	 between	
1:10,000	and	1:100,000	births),	characterized	by	the	appearance	 in	 first	decade	
of	 life	 of	 multiple	 hamartomatous	 polyps	 (	 affecting	 the	 entire	 gastrointestinal	
tract),	 mucocutanous	 melanosis,	 luminal	 gastro-intestinal	 cancer	 and	
extraintestinal	cancer.	
	
Similarly,	 Juvenile	Polyposis	Syndrome	(JPS)	 is	characterized	by	 the	appearence	
of	several	juvenile	polyps	in	the	gastro-intestinal	tract.	The	incidence	is	estimated		
between	1:100.000	to1:160	000	[29].	 













Age	 and	 sex:	 colorectal	 tumor	 are	 more	 diffused	 among	 elderly	 people;	 in	
particular	 incidence	 rate	 increases	 after	 60	 years,	 expecially	 in	 male.	 Among	
















the	 same	 rate	 of	 incidence	 of	 the	 host	 country	 polulation,	 due	 to	 new	 eating	

























































The	 likelihood	of	 the	onset	of	new	adenomas	after	treatment	 for	previous	colon	
cancer	also	seems	to	decrease	with	these	medications.	Their	efficacy	is	reported	
both	when	the	therapy	is	administered	at	an	extremely	early	stage	of	the	disease	




	Among	 medicines	 particular	 attention	 has	 been	 paid	 to	 selective	 inhibitors	 of	
COX-2	(such	as	celecoxib	and	rofecoxib),	an	inducible	enzyme	responsible	for	the	










a	 5-year	 survival	 rate	 of	 about	 90%.	 The	 transformation	 from	 adenoma	 to	
carcinoma	 is	 generally	 quite	 slow	 (it	 can	 last	 10	 years):	 this	 period	 gives	 the	
patient	 the	possibility	 to	diagnose	an	asimptomatic	 lesion	at	 an	early	 stage	and	
eliminate	it.	These	so	important	screening	methods	are	based	on	search	for	occult	
blood	 in	 the	 stool	 (Hemoccult),	 sigmoidoscopy	 with	 flexible	 instrument,	
colonoscopy	and	double-contrast	 clism.	Other	 tests,	 such	as	 research	 in	 stool	of	
altered	DNA	and	virtual	colonoscopy,	are	also	being	 tested,	but	 further	data	are	
needed.		
Today	 in	 many	 countries	 medical	 guidelines	 recommend	 colorectal	 cancer	
screening	 programs	 from	 age	 of	 50	 for	 people	 at	 average	 risk:	 they	 generally	
consist	of	annual	or	biannual	guaiac	faecal	occult	blood	or	faecal	immunochemical	
tests,	 flexible	 sigmoidoscopy	 every	 5	 years,	 or	 colonoscopy	 every	 10	 years	
[39,40].	
A	 positive	 faecal	 immunochemical	 test	 or	 guaiac	 faecal	 occult	 blood	 requires	 a	
mandatory	colonoscopy.	If	adenomas	and		hyperplastic	polyps	are	detected,	they	
have	to	be	removed	and	an	histologiacal	analysis	has	to	be	performed.	
Individuals	 with	 increased	 risk	 (for	 exemple	 first-degree	 relatives	 of	 young	
patients	 diagnosed	 with	 colorectal	 cancer,	 familial	 adenomatous	 polyposis,	









rectal	 bleeding	 and/or	 alvus	 alterations	 in	 elderly	 patients	with	 risk	 factors.	 In	
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Italy,	 screening	 programs	 are	 based	 on	 the	 detection	 of	 occult	 blood	 in	 stools.	
Peolpe	of	both	sexes,	aged	between	50	and	69	years,	are	 invited	to	perform	the	
exam	every	2	years	without	dietary	restrictions.	If	the	test	result	is	positive,	it	is	
indicated	 to	 perform	 further	 investigations	 (colonoscopy	 or	 opaque	 clism)	 in	
order	to	identify	the	main	cause	of	the	bleeding.		
The	clinical	examination	can	help	to	make	an	initial	assessment	of	rectum,	since	
this	 district	 represents	 one	 of	 the	 most	 frequent	 locations	 of	 large	 intestine	
neoplasms.	However,	the	accuracy	of	the	exam	can	change	according	to	clinician	
experience.	 Furthermore,	 it	 is	 not	 clinically	 possible	 to	 distinguish	 between	 an	
inflammatory	disease	and	a	tumor.		
Among	 instrumental	 examinations	 the	 endoscopic	 analysis	 is	 essential	 and	
represents	 the	gold	standard	 for	diagnosis.	This	procedure	allows	 to	explore	all	
segments	 of	 the	 colon	 and	 gives	 the	 possibility	 to	 take	 biopsy	 samples	 of	 a	
suspected	 lesion	 in	 order	 to	 analyse	 it	 from	 an	 histological	 point	 of	 view.	
Furthermore,	 this	 colonscopy	 has	 a	 possible	 preventive	 role,	 allowing	 the	
definitive	 removal	 of	 precancerous	 lesions	 like	 polyps.	 A	complemetary	
examination	 is	 represented	 by	 double-contrast	 barium	 enema,	 which	is	 a	 form	
of	contrast	 radiography	:	 a	 liquid	 containing	barium	and	 air	are	 put	 into	 the	
rectum	 and	 colon	 to	 evaluate	 the	 morphology	 of	 the	 intestine	 and	 detect	 the	




Other	 instrumental	 diagnostic	 investigations,	 such	 as	 Computed	 Tomography	
(CT)	 of	 the	 abdomen	 and	 eco-endoscopy,	 are	 mainly	 used	 for	 cancer	 staging	
purposes,	 as	 they	document	possible	dissemination	at	 a	distance,	however	 they	
play	a	limited	role	in	diagnosis.		
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Laboratory	 tests	 can	 also	 help	 diagnostic	 procedures;	 tumour	markers,	 such	 as	
CEA	(carcinoembryonic	antigen),	gastrointestinal	tumour	antigen	CA	19.9	and	CA	
125,	 which	 are	 generally	 present	 at	 low	 levels	 in	 samples	 taken	 from	 healthy	
subjects,	 can	 raise	 in	 patients	 affected	 by	 cancer,	 so	 they	 may	 represent	 an	
indicator	of	the	presence	of	neoplastic	disease.	Unfortunately,	the	value	of	these	
substances	 is	 often	 influenced	 by	 other	 non-neoplastic	 factors	 such	 as	 drug	
therapies	 (some	antihypertensive	drugs)	 and/or	 the	presence	of	 other	diseases	





Despite	 these	 considerations,	 final	 diagnosis	 of	 this	 cancer	 is	 made	 only	 by	
histological	analysis	from	biopsy	samples.		
	










Several	 classification	 	 systems	 can	 be	 used.	 Although	 modern	 TNM	 method	 is	
generally	 adopted,	 Dukes	 classification,	 proposed	 by	 Dr.	 Cuthbert	 E.	 Dukes	 in	
1932,	 is	 still	 diffused	 as	 it	 is	 simple,	 essential	 and	 reproducible	 and	 focuses	 on	





















Finally	 in	 1978	 the	American	 Joint	 Committee	 for	 Cancer	 (AJCC)	 developed	 the	
modern	TNM	system,	valid	for	both	colic	and	rectal	tumours.	This	establishes	the	










































In	case	of	colon	cancer	tumor,	 the	 lesion	together	with	 its	corresponding	 lymph	
vessels	should	be	removed.		
Open	 surgery	 tecnique	 has	 been	 the	 only	 option	 available	 for	 many	 years,	 but	
laparoscopic	 technique	 is	 a	 valid	 alternative	 nowadays.	 This	 method	 lets	 the	
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patient	 	achieve	similar	 long-term	results	as	open	surgery	 , with	a	reduced	need	
for	 blood	 transfusions	 (3.4%	 vs	 12.2%),	 faster	 return	 of	 bowel	 function	 and	 a	




Data	 for	 the	 role	 of	 neoadjuvant	 radiotherapy	 in	 locally	 advanced	 colon	 cancer	
are	not	so	clear.	 	The	main	goal	of	 this	 treatment	 is	 to	reduce	the	probability	of	
local	 recurrence	but	 several	 side	 effects	 have	 to	be	 considered.	 Stage	 I	 patients	
should	not	 be	 treated	 in	 addition	 to	 surgery	 because	 of	 the	 the	 low	 recurrence	
rate	(less	than	3%)	[49].	
Stage	 III	 patients	may	 benefit	 from	 additional	 treatment,	 whereas	 opinions	 for	
patients	with	stage	II	are	controversial	[50].	
	
Otherwise,	 adjiuvant	 chemoterapy	 is	 reccomendef	 for	 patients	 with	 stage	 III	
disease.	 Fluorouracil	 and	 capecitabine	 are	 the	most	 common	 drugs.	 In	 stage	 II	
colon	cancer	patients	 the	survival	benefits	 from	adjuvant	chemotherapy	are	not	
so	many,	so	it	is	reccomended	only	in	cases	with	higher	risk	of	relapse.		
Considering	 distant	 metastases,	 patients	 with	 resectable	 liver	 or	 lung	 lesions	
should	undergo	surgical	resection	while	those	with	irresectable	metastases	might	










between	 human	 microbiota	 	 and	 other	 gastrointestinal	 tumours	 could	 be	
hypotized.	 Recent	 data	 suggests	 some	 bactaeria	 can	 have	 a	 role	 in	 the	
pathogenesis	 of	 colorectal	 carcinoma,	 in	 fact	 they	 have	 been	 detected	 in	 tumor	

















	For	 exemple	 It	 has	 been	 associated	 with	 oral	 cancer	 and	 premature	
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stillbirths[55],	pancreatic	cancer.		
In	 addition,	 	 a	 correlation	with	 liver	 abscess,	 appendicitis,	 sinusitis,	mastoiditis	
and	tonsillitis	has	to	be	considered	[56,57,58].	
In	this	specific	case,	some	recent	studies	found	Fusobacterium	nucleatum	rates	to	




due	 to	 its	 	 intrinsic	 aptitude	 to	 adhere	 and	 invade	 human	 epithelial	 and	
endothelial	cells.	
That	is	the	reason	why	the	hypotesis	that	human	oral	microbiota	is	not	confined	
to	 the	mouth	 but	 is	 able	 to	move	 in	 the	 body,	 causing	 extra-oral	 infection	 and	
inflammation,	is	plausible.	
It	 is	 true	 that	 the	 presence	 of	 this	 bacterium	 in	 the	 colorectal	 adenomas	 and	
carcinomas	is	not	sufficent	to	demostrate	a	direct	causality,	but	the	fact	that	oral	
cavity	 is	 the	 starting	 point	 of	 the	 digestive	 tract	 has	 to	 be	 considered:	 some	
bacteria	could	be	able	to	move	towards	the	bowel.		
The	 surface	 adhesin	 FadA	 expressed	 by	 this	 micoorganism	 is	 essential	 in	 cell	
attachment	and	invasion	processes	[60].		
Furthermore,	 FadA	 can	 bind	 to	 endothelial-cadherin	 on	 endothelialn	 vascular	
cells,	increasing	their	permeability	and	allowing	bacteria	to	penetrate.	This	could	
result	 in	 an	 increased	 bacterium	 penetration	 and	may	 represent	 a	 strategy	 for	












of	 colorectal	 cancer,	 in	 fact	 they	 showed	 that	 FadA	 (Fusobacterium	 Nucleatum	
adhesin	 A)	 adhesion	 on	 epitelium	 and	 endothelial	 cells	 can	 induce	 human	
colorectal	cancer	tissue	growth	[63].		
F.	nucleatum	can	binds	to	both	normal	and	tumoral	epitelium,	but	tissue	growth	
is	 promoted	 only	 in	 the	 second	 case.	 The	 cancerogenetic	 pathway	 could	 be	 the	
following:	 FadA	 binding	 to	 E-cadherin	 on	 epitelial	 tumoral	 cells	 activates	 b-
catenin-regulated	 transcription;	 this	 consequently	 increases	 the	 expression	 of	
oncogenes	 (cyclin	 D1	 and	 c-Myc),	 Wnt	 signalling	 genes	 (Wnt7a,	 Wnt7b,	 and	
Wnt9a)	 and	 inflammatory	 genes	 (NFk-B,	 TNF-alpha,	 IL-6,	 IL-8,	 and	 IL-18;	 the	
result	 is	 the	 creation	 of	 an	 inflammatory	 microenvironment	 which	 helps	 the	
progression	 of	 tumor).	 	 If	 	 FadA	 binding	 site	 on	 E-cadherin	 is	 blocked	 by	 a	 	 a	
synthetic	 peptide	 the	 cancerogenic	 pathway	 can	 be	 stopped	 and	 tumor	 growth	
can	be	slowed	both	in	vitro	and	in	xenograft	mice	[63].		
	
Kostic	 and	 al	 found	 that	 short-chain	 fatty	 acids	 and	 short-peptides	
(formylmethionyl-leucyl-phenylalanine)	 released	 by	 the	 bacterium,	 can	 attract	
myeloid-derived	suppressor	cells	(MDSCs)	[64].	
In	addition,	 it	 seems	 that	 infected	cells	 increase	 the	expression	of	microRNA-21	
(miR21)	 by	 activating	 TLR4	 signaling	 to	 MYD88,	 which	 leads	 to	 a	 further	
activation	of	NF-κB,	inducing	the	oncogenic	pathway	[65].	
Furthermore,	 it	 has	 been	 found	 that	 the	 interaction	 between	 bacterial	 Fap2	 (a	
galactose-sensitive	 adhesion	 protein)	 and	 the	 human	 inhibitory	 receptor	 TIGIT	
can	 induce	 human	 lymphocytes	 cell	 death	 and	 generate	 a	 tumor	





















Its	 main	 virulence	 factor	 are	 represented	 by	 Arg-gingipain	 (Rgp)	 and	 lys-
gingipain	(Kgp)	,	Capsular	polysaccharide	(CPS)	and		Fimbriae.	
In	 particular	 Arg-gingipain	 (Rgp)	 and	 lys-gingipain	 (Kgp)	
are	endopeptidase	enzymes,	 essential	 for	 bacterial	 collection	 of	 nutrients,	
adhesion,	 invasion	 and	 colonization.	 Furthermore,	 these	 enzymes	 are	 able	 to	
protect	the	bacterium	from	the	host	immune	response.	
P.	gingivalis	plays	a	major	role	in	the	onset	of	chronic	periodontitis	[68].	
	Though	 it	 can	be	detected	 in	 low	abundance	 in	 the	mouth,	 it	 is	 able	 to	 cause	a	
microbial	shift	of	the	oral	cavity,	allowing	for	huge	growth	of	the	miocrobiota.	The	




that	 Pg	 is	 able	 to	 alter	 host-microbe	 equilibrium	 and	 cause	 inflammatory	
responses	by	modulating	the	complement	system	in	extra-oral	tissues.		
	
A	 study	 suggested	 a	 role	 of	 PG	 heat-shock	 protein	 in	 infection-triggered	
autoimmune	diseases	[69].		By	means	of	peptidylarginine	deiminase	(PAD),	which	










of	 subcutaneous	 infection	 with	 Pg	 at	 different	 gestation	 periods	 was	 lower	
maternal	weight	gain,	lower	fetus	weight	and	lower	placenta	weight	[73].		
Virulence	 may	 vary	 according	 to	 bacterium	 strain:	 	 in	 a	 mouse	 periodontitis	






























This	 research	 project	 aimed	 to	 verify	 the	 presence	 of	 a	 possible	 correlation	
between	oral	microbiota	and	colorectal	 carcinoma.	 In	particular	 the	 role	of	 two		
specific	 sub-gingival	 bacteria,	 Fusobacterium	 nucleatum	 and	 Porphyromonas	
gingivalis,	two	pathogens	which	are	present	in	the	oral	cavity	and	increase	their	











at	 risk	 of	 developing	 colorectal	 cancer,	 who	 needed	 to	 undergo	 a	 diagnostic	





























Then	patients	were	asked	to	provide	 information	about	 their	medical	 therapies,	
medications,	diseases,	allergies,	smoking,	eating	habits	(consumption	of	red	and	
processed	meat,	 consumption	 of	 vegetables	 and	 fruit,	 consumption	 of	 alcohol),	













Gingival	 crevicular	 fluid	was	 collect	 by	 inserting	 4	 sterile	 paper	 cones	 (one	 for	
each	 quadrant)	 into	 the	 deepest	 periodontal	 pocket	 of	 each	 quadrant,	 for	 30	
seconds.	 Furthermore,	 4	 sterile	 paper	 cones	 (one	 for	 each	 quadrant)	 were	
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A	 diagnostic	 colonscopy	 was	 performed	 on	 each	 patient	 in	 order	 to	 verify	 the	
prescence	 of	 colorectal	 lesions.	 All	 lesions	were	 biopsied	 in	 order	 to	 perform	 a	






• Patients	 with	 a	 positive	 histological	 diagnosis	 for	 colorectal	 adenoma	
(group	2)	















sample,	 and	 a	 subsequent	 phase	 of	 purification,	 common	 to	 all	 two	 types	 of	






















proteinase	K	 (20	mg/ml)	 in	 order	 to	 degrade	 the	 tissue	 and	 digest	 the	 nuclear	
membrane,	thereby	isolating	the	total	DNA	(human	and	bacterial).	
The	 samples	 were	 then	 processed	 automatically	 using	 the	 QIAcube	 HT	
instrument.	This	instrument	uses	an	extraction	kit	that	binds	the	DNA	to	the	resin	
of	 a	 purification	 column,	 two	 successive	 washes	 with	 solutions	 containing	























The	 fragments	 of	 intestinal	 mucosa	 subjected	 to	 biopsy,	 taken	 from	 all	 three	

















10	 operating	 system.	 Descriptive	 statistics	 of	 continuous	 variables	 were	
presented	 as	mean ± standard	 deviation	 (SD)	 whereas	 the	 categorical	 variables	
were	presented	as	numbers	and	frequencies.	
Bacterial	 load	 comparison	between	patients	 groups	was		 performed		 by	ANOVA	
and	 Dunnet	 post	 hoc	 test.	 Data	 were	 also	 processed	 with	 the	 non-parametric	
Kruskal-Wallis	statistics	because	data	did	not	always	fit	the	Gaussian	distribution.	
In	order	to	establish	in	this	study	if	there	were	any	possible	connections	between	
oral	 and	 intestinal	microflora,	 correlation	 analysis	 was	 performed	 to	 statistical	
Patients with risk for Colorectal Cancer (CC) 
(fecal blood; symptoms)
Anamnesis Questionnaire 
(age, sex, smoking, consumption of alcohol and red-processed meat, physical activity, diabetes, other risk factors)
Periodontal analysis 


































































DIAGNOSIS N Minimum Maximum Mean Std. Deviation 
Cancer 
AGE 10 58 89 74.30 10.781 
Valid N (listwise) 10     
Adenoma 
AGE 50 49 82 64.50 7.192 
Valid N (listwise) 50     
Healthy 
AGE 55 41 77 61.00 7.604 




In	 group	 1	 ages	 registered	 assessed	 between	 58	 and	 89,	 with	mean	 age	 of	 74	
years.	In	group	2	ages	registered	assessed	between	49	and	82,	with	mean	age	of	
64,5	 years.	 In	 group	3	 ages	 registered	 assessed	between	41	 and	77,	with	mean	
age	of	61	years.	
	
SEX * DIAGNOSIS Crosstabulation 
 DIAGNOSIS Total 
Cancer Adenoma Healthy 
SEX Male 
Count 6 34 29 69 
% within SEX 8.7% 49.3% 42.0% 100.0% 
	 84	
% within DIAGNOSIS 60.0% 66.7% 50.9% 58.5% 
% of Total 5.1% 28.8% 24.6% 58.5% 
Female 
Count 4 17 28 49 
% within SEX 8.2% 34.7% 57.1% 100.0% 
% within DIAGNOSIS 40.0% 33.3% 49.1% 41.5% 
% of Total 3.4% 14.4% 23.7% 41.5% 
Total 
Count 10 51 57 118 
% within SEX 8.5% 43.2% 48.3% 100.0% 
% within DIAGNOSIS 100.0% 100.0% 100.0% 100.0% 
% of Total 8.5% 43.2% 48.3% 100.0% 
	
Tab	6	Sex	of	patients	in	the	three	groups	









periodontal	 pocket,	 in	 healty	 intestinal	 mucosa	 and	 in	 pathological	 intestinal	
mucosa:	
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
CTRLGINGFN 105 0 618315 15574.13 64257.936 
CTRLGINGPG 105 0 1389416 26321.28 154800.531 
CTRLGIGTOT 105 2828 8471355 686900.42 1275358.242 
PATHGINGFN 105 0 4005968 135482.55 505242.319 
PATHGIGPG 105 0 5426336 119166.04 667728.682 
PATHGINGTOT 105 1795 11266334 1402977.73 2368375.350 
CTRLBOWFN 118 0 2041008 19854.31 187967.399 
CTRLBOWPG 118 0 9654 173.73 1139.774 
CTRLBOWTOT 118 5959 2209906 168561.93 287797.752 
PATHBOWFN 64 0 4278689 68739.33 534621.843 
PATHBOWPG 64 0 3469 78.52 447.350 
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PATHBOWTOT 64 2547 13841040 353473.39 1723649.678 







DIAGNOSIS N Minimum Maximum Mean Std. Deviation 
Cancer 
CTRLGINGFN 5 0 1949 389.80 871.619 
CTRLGINGPG 5 0 2130 499.40 925.282 
CTRLGIGTOT 5 2935 74367 18147.00 31440.195 
PATHGINGFN 5 0 302936 60664.20 135434.156 
PATHGIGPG 5 0 29469 6076.40 13081.980 
PATHGINGTOT 5 2940 1872731 377555.60 835829.180 
CTRLBOWFN 10 0 2041008 209356.80 643769.750 
CTRLBOWPG 10 0 45 4.50 14.230 
CTRLBOWTOT 10 23631 2209906 414710.70 653272.680 
PATHBOWFN 10 0 4278689 431133.40 1351905.131 
PATHBOWPG 10 0 359 40.10 112.399 
PATHBOWTOT 10 26088 13841040 1492580.30 4339640.495 
Valid N (listwise) 5     
Adenoma 
CTRLGINGFN 46 0 618315 20350.20 91261.136 
CTRLGINGPG 46 0 17619 1917.61 4291.729 
CTRLGIGTOT 46 2828 5166896 491986.15 905009.373 
PATHGINGFN 46 0 4005968 129797.41 591322.450 
PATHGIGPG 46 0 4182093 107644.50 615512.182 
PATHGINGTOT 46 1795 9963334 1157202.09 1937110.075 
CTRLBOWFN 51 0 96270 4239.55 14798.358 
CTRLBOWPG 51 0 21 1.69 3.987 
CTRLBOWTOT 51 5959 1398011 236417.57 289746.108 
PATHBOWFN 51 0 31494 1725.16 5214.099 
PATHBOWPG 51 0 3469 90.63 499.070 
PATHBOWTOT 51 2547 1255353 133558.27 202949.469 
Valid N (listwise) 46     
Healthy 
CTRLGINGFN 54 0 153604 12911.59 31338.028 
CTRLGINGPG 54 0 1389416 49500.50 214194.385 
CTRLGIGTOT 54 2850 8471355 914860.11 1538863.003 
PATHGINGFN 54 0 2462323 147253.07 449379.692 
PATHGIGPG 54 0 5426336 139451.94 742613.442 
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PATHGINGTOT 54 2101 11266334 1707288.67 2742633.218 





DIAGNOSIS N Minimum Maximum Mean Std. Deviation 
Healthy CTRLBOWPG 57 0 9654 357.35 1627.183 
CTRLBOWTOT 57 18877 299456 64665.00 59204.433 
PATHBOWFN 3 0 0 .00 .000 
PATHBOWPG 3 0 2 .67 1.155 
PATHBOWTOT 3 29135 602340 295007.33 288842.885 




















 N Minimum Maximum Mean Std. Deviation 
POCKET1 82 2 8 4.28 1.552 
POCKET2 81 2 9 4.52 1.811 
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POCKET3 87 2 10 4.49 1.776 
POCKET4 85 2 10 4.68 1.907 








DIAGNOSIS N Minimum Maximum Mean Std. Deviation 
Cancer 
POCKET1 3 2 4 3.00 1.000 
POCKET2 2 2 3 2.50 .707 
POCKET3 4 3 5 3.38 .750 
POCKET4 4 2 5 3.25 1.258 
      
Adenoma 
POCKET1 33 2 7 4.47 1.541 
POCKET2 33 2 9 4.59 1.839 
POCKET3 38 2 9 4.41 1.766 
POCKET4 36 2 10 4.68 1.852 
      
Healthy 
POCKET1 46 2 8 4.23 1.570 
POCKET2 46 2 9 4.57 1.797 
POCKET3 45 2 10 4.67 1.831 
POCKET4 45 2 10 4.81 1.975 






Looking	 at	 intestinal	 samples,	 Fusobacterium	 nucleatum	 load,	 Phorpyromonas	
gingivalis	load	and	the	total	bacterial	load	was	calculated	in	the	three	groups	on	
healty	and	pathological	mucosa	and	Oneway	ANOVA	was	performed	 in	order	 to	







 Sum of Squares df Mean Square F Sig. 
CTRLBOWFN 
Between Groups 392723628199.908 2 196361814099.954 6.036 .003 
Within Groups 3741090307847.491 115 32531220068.239   
Total 4133813936047.398 117    
CTRLBOWPG 
Between Groups 3717786.859 2 1858893.430 1.442 .241 
Within Groups 148275262.463 115 1289350.108   
Total 151993049.322 117    
CTRLBOWTOT 
Between Groups 1456006549710.848 2 728003274855.424 10.167 .000 
Within Groups 8234816333956.609 115 71607098556.144   
Total 9690822883667.457 117    
PATHBOWFN 
Between Groups 1556505775642.964 2 778252887821.482 2.886 .063 
Within Groups 16450186679037.143 61 269675191459.625   
Total 18006692454680.105 63    
PATHBOWPG 
Between Groups 40420.496 2 20210.248 .098 .907 
Within Groups 12567255.488 61 206020.582   
Total 12607675.984 63    
PATHBOWTOT 
Between Groups 15452395922518.312 2 7726197961259.156 2.745 .072 
Within Groups 171718601435668.900 61 2815059039928.999   






Similarly	 a	 P	 value	 of	 0.000	 was	 found	 considering	 the	 total	 bacterial	 load	 on	
healty	mucosa.		
On	the	other	hand	the	Pg	load	on	healty	mucosa	is	not	significative.	
Both,	 single	 bacterial	 load	 (Pg	 and	 Fn)	 and	 total	 bacterial	 load	 on	 pathological	
mucosa	do	not	show	significative	values.	
	
These	 differences	 are	 due	 to	 higher	 mean	 values	 of	 Fusobacterium	 nucleatum	
load	 on	 healty	 mucosa	 in	 patients	 with	 diagnosis	 of	 carcinoma	 compared	 to	




It	 is	 very	 interesting	 to	note	 that	 intermediate	values	 (fewer	 than	 cancer	group	
but	 higher	 than	 control	 group)	 can	 be	 observed	 in	 patients	with	 a	 diagnosis	 of	
adenoma,	which	can	actually	be	considered	a	potential	precancerous	lesion.	















Std. Error Sig. 95% Confidence Interval 




 61837.247 .002 69105.01 348449.86 
Adenoma Healthy 3660.181 34764.784 .993 -74863.39 82183.76 
CTRLBOWPG 
Cancer Healthy -352.851 389.301 .590 -1232.17 526.47 




 91744.072 .000 142822.42 557268.98 
Adenoma Healthy 171752.569
*
 51578.345 .002 55252.03 288253.11 
PATHBOWFN 
Cancer Healthy 431133.400 341846.822 .290 -313883.78 1176150.58 
Adenoma Healthy 1725.157 308511.717 1.000 -670641.87 674092.18 
PATHBOWPG 
Cancer Healthy 39.433 298.790 .979 -611.75 690.61 
Adenoma Healthy 89.961 269.654 .881 -497.72 677.64 
PATHBOWTOT 
Cancer Healthy 1197572.967 1104472.235 .379 -1209501.60 3604647.54 
Adenoma Healthy -161449.059 996769.908 .969 -2333798.37 2010900.25 
*. The mean difference is significant at the 0.05 level. 














 DIAGNOSIS N Mean Rank 
CTRLBOWTOT 
Cancer 10 79.40 
Adenoma 51 74.06 
Healthy 57 42.98 















Asymp. Sig. .000 
a. Kruskal Wallis Test 







Cancer Adenoma Healthy 
CTRLBOWTOT 
> Median 8 36 15 
















Asymp. Sig. .000 
a. Grouping Variable: DIAGNOSIS 
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b. 0 cells (0.0%) have expected frequencies less than 5. The 


















 DIAGNOSIS N Mean Rank 
CTRLGINGFN 
Cancer 5 34.80 
Adenoma 46 53.26 
Healthy 54 54.46 
Total 105  
CTRLGINGPG 
Cancer 5 51.00 
Adenoma 46 52.76 
Healthy 54 53.39 
Total 105  
CTRLGIGTOT 
Cancer 5 58.69 
Adenoma 46 49.78 
Healthy 54 21.20 
Total 105  
PATHGINGFN 
Cancer 5 45.30 
Adenoma 46 56.42 
Healthy 54 50.80 
Total 105  
PATHGIGPG 
Cancer 5 49.00 
Adenoma 46 53.82 
Healthy 54 52.68 
Total 105  
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PATHGINGTOT 
Cancer 5 26.80 
Adenoma 46 52.70 
Healthy 54 55.69 
Total 105  
CTRLBOWTOT 
Cancer 10 79.40 
Adenoma 51 74.06 
Healthy 57 42.98 




















Chi-Square 2.196 .040 7.847 1.347 .135 4.125 25.912 
df 2 2 2 2 2 2 2 
Asymp. 
Sig. 
.334 .980 .020 .510 .935 .127 .000 
a. Kruskal Wallis Test 














Cancer Adenoma Healthy 
CTRLGINGFN 
> Median 1 22 29 
<= Median 4 24 25 
CTRLGINGPG 
> Median 2 20 26 
<= Median 3 26 28 
CTRLGIGTOT 
< Median 0 20 32 
>= Median 5 26 22 
PATHGINGFN 
> Median 1 27 24 
<= Median 4 19 30 
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PATHGIGPG 
> Median 2 25 25 
<= Median 3 21 29 
PATHGINGTOT 
> Median 1 21 30 
<= Median 4 25 24 
CTRLBOWTOT 
> Median 8 36 15 










N 105 105 105 105 105 105 118 
















df 2 2 2 2 2 2 2 
Asymp. Sig. .337 .866 .022 .146 .659 .246 .000 
a. Grouping Variable: DIAGNOSIS 
b. 2 cells (33.3%) have expected frequencies less than 5. The minimum expected cell frequency is 2.5. 
c. 2 cells (33.3%) have expected frequencies less than 5. The minimum expected cell frequency is 2.3. 




The	 previous	 data	were	 confirmed	 ,	 in	 fact	 a	 significative	 difference	 have	 been	





























































.803 .570 .968 .834 .745 .698 .781 .680 .834 .788 .820 



















.000 .750 .000 .000 .689 .028 .669 .657 .588 .590 

















.908 .001 .000 .274 .344 .390 .602 .480 .682 










 -.010 -.037 -.029 .047 .010 .046 
Sig. (2-
tailed) 
.968 .750 .908 
 
.000 .000 .922 .706 .769 .735 .945 .741 














 -.033 -.020 -.044 -.016 -.031 -.020 
Sig. (2-
tailed) 
.834 .000 .001 .000 
 
.000 .737 .840 .658 .911 .822 .888 















 1 -.033 -.043 -.022 .060 -.088 .062 
Sig. (2-
tailed) 
.745 .000 .000 .000 .000 
 
.735 .663 .825 .664 .527 .654 







-.038 -.040 -.108 -.010 -.033 -.033 1 -.016 .666
**
 .011 -.025 -.002 
Sig. (2-
tailed) 
.698 .689 .274 .922 .737 .735 
 
.862 .000 .932 .843 .988 








 .093 -.037 -.020 -.043 -.016 1 -.062 -.041 .146 -.031 
Sig. (2-
tailed) 
.781 .028 .344 .706 .840 .663 .862 
 
.504 .749 .251 .807 







-.041 -.042 -.085 -.029 -.044 -.022 .666
**
 -.062 1 .063 .043 .057 
Sig. (2-
tailed) 
.680 .669 .390 .769 .658 .825 .000 .504 
 
.619 .736 .654 











.834 .657 .602 .735 .911 .664 .932 .749 .619 
 
.857 .000 






-.037 -.075 -.098 .010 -.031 -.088 -.025 .146 .043 -.023 1 -.029 
Sig. (2-
tailed) 
.788 .588 .480 .945 .822 .527 .843 .251 .736 .857 
 
.818 







-.032 -.075 -.057 .046 -.020 .062 -.002 -.031 .057 .993
**
 -.029 1 
Sig. (2-
tailed) 
.820 .590 .682 .741 .888 .654 .988 .807 .654 .000 .818 
 
N 54 54 54 54 54 54 64 64 64 64 64 64 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
	
Tab.	 17	 Correlations	 between	 intestinal	 and	 gingival	 conditions	 considering	 all	
patients	
	




















































.622 .678 .687 .673 .685 .679 .685 .224 .687 .685 .675 






-.302 1 -.057 -.302 -.275 -.301 -.304 .985
**







.927 .621 .654 .623 .619 .002 .266 .621 .002 .627 











.659 .651 .659 .679 .713 .339 .659 .713 .655 






















.687 .621 .659 
 
.000 .000 .000 .685 .382 .000 .685 .000 



















.673 .654 .651 .000 
 
.000 .000 .719 .397 .000 .719 .000 























.685 .623 .659 .000 .000 
 
.000 .687 .384 .000 .687 .000 












 1 -.114 .968
**




.679 .619 .679 .000 .000 .000 
 
.753 .000 .819 .723 .795 













.685 .002 .713 .685 .719 .687 .753 
 
.630 .758 .000 .781 







.662 -.618 -.548 .508 .495 .507 .968
**
 -.174 1 .013 -.196 .003 
Sig. (2-
tailed) 
.224 .266 .339 .382 .397 .384 .000 .630 
 
.972 .588 .994 




















.687 .621 .659 .000 .000 .000 .819 .758 .972 
 
.728 .000 








 -.228 -.250 -.223 -.249 -.129 .997
**
 -.196 -.126 1 -.116 
Sig. (2-
tailed) 
.685 .002 .713 .685 .719 .687 .723 .000 .588 .728 
 
.750 
















 -.094 -.101 .003 1.000
**
 -.116 1 
Sig. (2-
tailed) 
.675 .627 .655 .000 .000 .000 .795 .781 .994 .000 .750 
 
N 5 5 5 5 5 5 10 10 10 10 10 10 
**. Correlation is significant at the 0.01 level (2-tailed). 
























































 .043 -.017 -.011 .014 -.057 .416
**




.000 .777 .911 .944 .924 .706 .004 .608 .689 .786 .906 








 1 -.065 -.057 -.046 .033 -.104 .381
**





.669 .706 .763 .826 .491 .009 .513 .575 .574 .389 






.043 -.065 1 -.036 -.024 .439
**





.811 .873 .002 .398 .460 .934 .469 .492 .901 










 -.025 -.043 -.088 -.022 .008 .004 
Sig. (2-
tailed) 
.911 .706 .811 
 
.000 .000 .867 .779 .563 .886 .957 .981 










 -.038 -.047 -.070 -.027 -.034 -.033 
Sig. (2-
tailed) 
.944 .763 .873 .000 
 
.000 .803 .757 .642 .861 .822 .827 













 1 -.037 -.120 .025 -.095 -.092 -.005 
Sig. (2-
tailed) 
.924 .826 .002 .000 .000 
 
.808 .426 .871 .528 .543 .972 






-.057 -.104 -.128 -.025 -.038 -.037 1 .060 .104 .392
**
 -.052 -.126 
Sig. (2-
tailed) 
.706 .491 .398 .867 .803 .808 
 
.675 .470 .004 .716 .379 
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 -.112 -.043 -.047 -.120 .060 1 .334
*
 -.124 .133 .046 
Sig. (2-
tailed) 
.004 .009 .460 .779 .757 .426 .675 
 
.017 .385 .354 .749 







-.078 -.099 .012 -.088 -.070 .025 .104 .334
*
 1 -.022 .084 .050 
Sig. (2-
tailed) 
.608 .513 .934 .563 .642 .871 .470 .017 
 
.878 .559 .725 






-.061 -.085 -.109 -.022 -.027 -.095 .392
**
 -.124 -.022 1 -.061 -.112 
Sig. (2-
tailed) 
.689 .575 .469 .886 .861 .528 .004 .385 .878 
 
.670 .433 






-.041 -.085 -.104 .008 -.034 -.092 -.052 .133 .084 -.061 1 -.070 
Sig. (2-
tailed) 
.786 .574 .492 .957 .822 .543 .716 .354 .559 .670 
 
.628 







-.018 -.130 .019 .004 -.033 -.005 -.126 .046 .050 -.112 -.070 1 
Sig. (2-
tailed) 
.906 .389 .901 .981 .827 .972 .379 .749 .725 .433 .628 
 
N 46 46 46 46 46 46 51 51 51 51 51 51 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
a. DIAGNOSIS = Adenoma 
	


























































.566 .334 .617 .692 .513 .164 .645 .570 . .000 .921 





















.001 .693 .000 .004 .654 .152 .448 . .000 .921 












 -.100 .080 -.041 .
b





.949 .001 .000 .473 .568 .770 . .671 .250 






.070 -.055 -.009 1 -.018 .432
**









.617 .693 .949 
 
.897 .001 .640 .644 .084 . .000 .000 










 -.018 1 .498
**









.692 .000 .001 .897 
 
.000 .706 .825 .782 . .000 .000 















 1 -.096 -.075 .098 .
b
 -.501 .921 
Sig. (2-
tailed) 
.513 .004 .000 .001 .000 
 
.488 .591 .482 . .666 .254 















.164 .654 .473 .640 .706 .488 
 
.616 .637 . .000 .000 
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.645 .152 .568 .644 .825 .591 .616 
 
.694 . .000 .000 














.570 .448 .770 .084 .782 .482 .637 .694 
 
. .938 .018 

































. . . . . . . . . 
 
. . 




















 1 -.124 
Sig. (2-
tailed) 
.000 .000 .671 .000 .000 .666 .000 .000 .938 . 
 
.921 



















 -.124 1 
Sig. (2-
tailed) 
.921 .921 .250 .000 .000 .254 .000 .000 .018 . .921 
 
N 3 3 3 3 3 3 3 3 3 3 3 3 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
a. DIAGNOSIS = Healthy 






The	 aim	 of	 the	 intestinal	 samples	 analysis	 was	 to	 evaluate	 the	 presence	 of	 a	







Significative	 differences	 among	 the	 groups	 were	 found	 considering	
Fusobacterium	nucleatum	 load	 (P=0,003)	and	 the	 total	bacterial	 load	 (P=0,000)	
on	healty	 intestinal	mucosa.	The	Dunnett	Test	 confirmed	higher	Fusobacterium	
nucleatum	loads	and	total	bacterial	loads	on	healty	intestinal	mucosa	of	patients	
with	cancer	 	compared	to	 the	control	group	(healty	patients).	 It	 is	significant	 to	
observe	 that	 patients	 with	 adenomas	 show	 intermediate	 values.	 The	 stepwise	
growing	 pattern	 of	 this	 specific	 bacterial	 loads	 from	 normal	 mucosa	 to	 the	
precancerous	 lesions	 (adenomas)	 and	 from	polyps	 to	malignant	 tumoar	 tissues	
reflects	the	results	of		Rubinstein	and	Wang	analysis	[63].	
	
Fusobacterium	 nucleatum	 is	 a	 typical	 oral	 bacterium	 that	 is	 responsible	 for	
periodontal	 disease,	 however	 it	 has	 been	 found	 in	 high	 loads	 in	 this	 extra-oral	
area,	which	can	be	 reached	by	means	of	 ingestion	of	 food	and	swallowing	 from	
the	 oral	 mouth.	 The	 higher	 load	 in	 patients	 with	 cancer	 and	 adenomas	 (pre-
malignant	lesions)	compared	to	control	group	makes	us	reflect	on	the	role	of	this	




The	 same	 differences	 can	 not	 be	 appreciated	 if	 we	 consider	 the	 analysis	 of	
pathological	mucosa,	but	this	may	be	due	to	the	alterations	already	occurred	on	
these	 tissues,	 which	 do	 not	 let	 the	 detection	 of	 a	 specific	 microrganism.	 In	
addition	 the	 role	 of	 oral	 microbiota	 could	 represent	 a	 risk	 factor	 in	 the	 first	
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the	 correlations	 tables	 :	 the	 presence	 of	 a	 single	 bacterium	 seems	 to	 foster	 the	





The	 presence	 of	 Porphyromoas	 gingivalis	 in	 intestinal	mucosa	 is	 significatively	
linked	to	that	one	of	 the	same	bacterium	in	gingival	 tissue	only	 in	patients	with	
diagnosis	of	adenoma	(P=0.009),	compared	to	the	situation	of	the	control	group,	
where	such	a	correlation	is	not	detectable.	This	may	be	due	to	the	fact	that	a	high	
bacterial	 load	 in	 oral	 gums,	 representing	 a	 natural	 reservoir	 for	 the	
microrgnaism,	 could	be	 related	 to	 a	major	probability	 of	 transition	 through	 the	
digestive	tract	by	means	of	swallowing.	The	colonization	of	intestinal	mucosa	by	
oral	 bacteria	 might	 be	 one	 of	 the	 causes	 of	 development	 of	 polyps	 in	 these	




In	 addition	 the	 same	 Phorphyromonas	 gingivalis	 intestinal	 load	 seems	 to	 be	
related	also	to	the	presence	of	Fusobacterium	nucleatum	in	periodontal	gums	of	
patients	 with	 diagnosis	 of	 adenoma	 (P=0.004),	 compared	 to	 the	 situation	 in	
healty	ones.	
Again	a	certain	cooperation	between	these	two	bacterial	pathogens	seems	to	be	





































In	 conclusion,	 the	 results	 of	 the	 study	 suggest	 that	 oral	 microbiota	 and	 in	
particular	 a	 specific	 bacterium,	 Fusobacterium	 nucleatum,	 so	 important	 in	
pathogenesis	 of	 periodontal	 disease,	 can	 have	 a	 role	 in	 colorectal	 cancer;	 in	
particular	 this	 microrganism	 may	 participate	 in	 that	 complex	 and	 still	 non	




The	 role	 of	 Phorpyromonas	 gingivalis,	 another	 typical	 periodontal	 bacterium,	
although	 detected	 in	 both,	 oral	 and	 intestinal	 mucosa,	 does	 not	 seem	 to	 be	
directly	correlated	with	carcinogenesis	but	 further	analysis	are	needed	since	 its	
behaviour	 in	 extra-oral	 tissues	 has	 been	 analysed	 only	 in	 few	 studies	 at	 the	
moment.	However	this	 last	particular	pathogen	could	promote	the	development	
of	Fusobacterium	nucleatum,	as	observed	from	correlations	on	gingival	samples	
and,	 above	 all,	 from	 those	 emerged	between	 intestinal	 and	 gingival	 samples	 on	
patients	who	have	already	developed	an	adenoma,	compared	to	healty	patients.	
A	 cross	 sectional	 study	 let	us	observe	 the	oral	 and	 intestinal	 conditions	of	non-
affected	and	affected	patients,	however	further	prospective	cohort	studies	will	be	
necesarry	 in	 order	 to	 enstablish	 the	 presence	 of	 a	 clearer	 causal	 link	 in	 the	
pathogenetic	 mechanism	 of	 this	 tumor.	 Anyway,	 it	 seems	 increasingly	 evident	
that	 emerging	 correlations	 between	 oral	 microbiota	 and	 extra-oral	 systemic	















Helicobacter	 pylori	 is	 a	widespread,	 Gram-negative,	microaerophilic	 bacterium,	
generally	 associated	 with	 chronic	 gastritis	 but	 also	 with	 acute	 gastritis,	 peptic	
ulcer	and	gastric	cancer.	It	was	firstly	described	in	1886	by	Prof.	W.	Jaworski,	but	
only	 in	 1979	 Warren	 found	 the	 presence	 of	 this	 microorganism	 in	 gastric	
epithelium	 samples	 collected	 during	 gastric	 biopsies.	 	 Robin	Warren	 and	 Barry	












The	 motility	 of	H.	 pylori	is	 permitted	 by	 the	 presence	 of	 5-6	 unipolar	 flagella	
(molecular	weight	of	50,000-62,000).	The	shape	 is	helicoidal	 in	active	 form	and	
coccoid	in	latency.	It	shows	a	slighty	toxic	lipopolysaccharide	containing	Lipid	A	





Fig.39 Optical Microscope image of Helicobacter pylori with its flagella 
 
	
It	 is	 precisely	 the	 presence	 of	 Urease	 that	 lets	 the	microorganism	 colonize	 the	
gastric	mucosa,	 in	fact,	by	converting	urea	into	ammonia	and	bicarbonate,	 it	can	











Although	 prevalence	 is	 reducing,	 about	 half	 of	 the	 worlwide	 population	 is	 still	
infected,	expecially	in	Southern	and	Eastern	Europe,	South	America	and	Asia.	
The	rate	of	infection	in	developing	countries	is	between	70	and	90%	and	here	the	



















H.pylori	 can	 survive	 in	 water	 for	 several	 days,	 so	 contaminated	 water	 could	
represent	an	important	reservoir	for	infection.	


















The	 disease’s	 evolution	 could	 be	 very	 slow	 and	 it	 depends	 on	 different	 factors:	
host’s	 defenses,	 bacterial	 genomics	 ,	 genetic	 predisposition,	 smoking	 and	 food	
habits.	 Only	 10-15%	 of	 	 patients	with	 active	 chronic	 gastritis	 develop	 a	 gastric	
ulcer.	Other	manifestations	 include	duodenal	ulcer,	 non-ulcer	dyspepsia,	 gastric	








In	 addition	 to	 its	 Urease	 activity,	 the	 bacterium	 produces	 dangerous	 virulence	














Gastric	 adenocarcinoma	 of	 the	 intestinal	 type1	 	 often	 develops	 from	 pre-







gastritis,	 NAG)	 →	 multifocal	 atrophic	 gastritis	 (MAG)	 without	 intestinal	
metaplasia	 →	 intestinal	 metaplasia	 of	 the	 complete	 (small	 intestine)	 type	 	 →	
intestinal	metaplasia	of	the	incomplete	(colonic)	type	→low-grade	dysplasia	(low-






Gastritis	 stage	 is	 characterized	 by	 infiltration	 of	 the	 lamina	 propria	 with	
mononuclear	 leukocytes	 and	 polymorphonuclear	 neutrophils,	 toghter	 with	
increase	 of	 cytokines	 ,	 interleukin	 (IL)-1b	 ,	 tumor	 necrosis	 factor	 (TNF)-a	 	 and	
interferon	(IFN)-g	.	
If	 gastritis	 is	not	 treated,	 it	may	evolve	 in	 two	ways:	 either	gastritis	 remains	as	
non-atrophic	or	it	progresses	with	several	damages	of	gastric	glands,	which	could	
finally	disappear	 (in	particular	 the	 cag-positive	vacA	 	 s1m1	strains	 seems	 to	be	
associated	with	galds	loss	and	precancerous	lesions)	[80].		
Fibrosis	 of	 the	 lamina	 propria	 is	 the	 following	 step,	 leading	 to	 a	 phenotypic	
change	of	normal	epithelial	 cells,	which	start	 showing	an	 intesinal	pattern.	Two	
main	morphological	kinds	of	Intestinal	metaplasia	are	known:	the	complete	type	
and	 the	 incomplete	 one.	 In	 complete	 type	 goblet	 cells	 interspersed	 among	

















	An	 alteration	 in	 cell	 morphology	 and	 architectural	 organization	 characterize	
dysplasia	 (or	non	 invasive	neoplasia).	Epithelium	appears	enlarged,	mitoses	are	
frequent,	 hyperchromatic	 and	 crowded	 nuclei	 can	 be	 observed,	 glands	 show	
irregular	 shapes.	 Different	 grades	 of	 dysplasia	 are	 known,	 according	 to	 several	
classifications.	 In	 any	 case	 cells	 remain	 within	 the	 bounds	 of	 the	 basement	
membrane.	 When	 this	 borders	 are	 crossed	 and	 degradation	 of	 intracellular	
matrix	occurs,	the	disease	becomes	an	invasive	carcinoma.	
Furthermore,	 Helicobacter	 pylori	 infection	 is	 correlated	with	MALT	 lymphoma,	
syderopenic	 anaemia,	 gynecological	 and	 dermatological	 diseases,	 idiopathic	









HP	 infection	 can	 be	 dectected	 by	 means	 of	 both,	 invasive	 and	 non-invasive	
methods.	
Invasive	 procedures	 includes	 esophagogastroduodenoscopy	 (associated	 with	
biopsy	for	histological	evaluation),	microbiological	examination	and	urease	rapid	
test.	
Non-invasive	 diagnostic	methods	 are	 based	 on	 serological	 analysis	 ,in	 order	 to	
detect	 specific	 serum	 IgM	 by	 means	 of	 Latex	 agglutination	 test,	 Elisa-test	 and	
Western	Blotting	Test.		
C-Breath	 Test	 Urea	 (C-BTU)	 measures	 the	 urease	 production	 of	 Hp.	 Enzyme	




radioactive	 carbon-13)	 on	 an	 empty	 stomach.	 If	 Helicobacter	 pylori	 is	 present,	














Antibiotics	 can	 reduce	 the	 amount	 of	H.	pylori	 present,	 as	well	 as	 proton	pump	
inhibitors	(PPI)	can	reduce	the	Urease		reaction,	so	this	test	should	be	performed	
only	14	days	after	 stopping	PPI	medication	or	28	days	after	 stopping	antibiotic	







Triple	 therapy	 is	 the	most	 used	 intervention	 regimen	 and	 it	 consists	 of	 double	
antibiotic	 medication	 (clarithromycin	 plus	 amoxicillin	 or	 metronidazole)	 and	 a	
Proton	Pump	Inhibitor	(PPI)	.	Duration	should	be	at	least	14	days.	
According	 yo	 guidelines	 elaborated	 during	 the	 Toronto	 Consensus	 Conference,	
[85]	therapy	is	reccomended	in	case	of:	gastric	or	duodenal	ulcer,	gastric	cancer	
and	 MALT	 lymphoma,	 chronic	 gastritis,	 non-ulcer	 dyspepsia,	 metaplasia,	
extragastric	 manifestations	 (idiopathic	 thrombocytopenic	 purpura)	 and	 for	
prevention	in	patient	at	high	risk	of	developing	gastic	cancer.	
Considering	 recent	 prevalence	 of	 clarithromycin	 and	metronidazole	 resistances	
(20%	 and	 30%	 of	 cases	 respectively),	 a	 quadruple	 therapy	 (metronidazole	























	Several	 studies	 have	 been	 conducted	 in	 order	 to	 understand	 if	 oral	 cavity	 and	
tonsils	 may	 represent	 a	 reservoir	 for	 HP	 and	 so	 a	 potential	 element	 for	
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effective,	 as	 shown	 by	 eradication	 rates	 which	 are	 below	 40%	 [93],	 and	 it	 is	
precisely	 this	 situation	which	could	cause	recrudescence	of	Hp	 infection.	 In	 fact	





analysis	 in	 order	 to	 valuate	 the	 presence	 of	 this	 bacterium	 in	 the	 oral	 cavity,	






















This	 study	 was	 conducted	 at	 the	 Department	 of	 Surgical	 and	 Morphological	






Inclusion	 criteria	 were:	 the	 presence	 of	 the	 signed	 informed	 consent,	 good	











A	 questionnaire	 was	 completed	 for	 each	 patient	 in	 order	 to	 register	 medical	








C-	Urea	Breath	 test	was	 performed:	 the	 patient	 swallowed	 carbon	 labeled	 urea	
















Specimens	 were	 processed	 to	 extract	 and	 purify	 DNA	 using	 a	 method	 that	
includes	 two	 consecutives	 incubations	 with	 lysozime	 and	 proteinase	 K.	 Once	
extracted,	 DNA	 was	 purified	 through	 a	 silica	 spin-column	 (Sigma-Aldrich,	 St.	
Louis,	MO,	 USA).	 Quantitative	 PCR	 of	 16S	 rRNA	 genes	was	 performed	with	 the	
hydrolysis	probes	method	to	identify	and	evaluate	the	amount	sequences	of	16S	
rRNA	 gene	 of	 the	 Human	 Oral	 Microbiome	 Database	 (HOMD	 16S	 rRNA	 RefSeq	
Version	10.1).	All	sequences	were	aligned	to	find	either	a	consensus	sequence	or	
less	 preserved	 spots,	 useful	 to	 optimize	 the	 specificity	 of	 primers	 and	 dual	
labelled	hydrolysis	probes.	Absolute	quantification	assays	were	performed	using	
a	 7500	 Sequence	 Detection	 System	 (Applied	 Biosystems).	 The	 thermal	 cycle	
included	 10	minutes	 incubation	 at	 95	 °C	 to	 activate	 polymerase,	 followed	 by	 a	
two-steps	 amplification	 of	 15s	 at	 95	 °C	 and	 60	 s	 at	 57	 °C	 for	 40	 cycles.	 Each	
experiment	 included	 non-template	 controls	 to	 exclude	 reagents	 contamination	
and	 serial	 diluitions	 of	 the	 specific	 synthetic	 template	 (Eurofin	 MWG	 Operon,	
Ebersberg,	Germany).	
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Plasmids	 containing	 bacterial	 target	 sequences	 were	 used	 to	 obtain	 standard	
curves	(Eurofin	MWG	Operon,	Ebersberg	Germany).	The	total	amount	of	bacterial	
charge	was	estimated	using	the	Thermo	Scientific	Nanodrop	spectrophotometer.	
Standard	 curves	 were	 created	 with	 serial	 diluitions	 between	 107	 and	 101	
plasmids	copies.	
The	 total	 quantification	 of	 absolute	 bacterial	 charges	 determined	 the	 relative	
amount	 of	 Helicobacter	 pylori.	 Under	 10	 U	 the	 results	 were	 considered	 as	
negative.	
Comparative	 statistics	 among	 the	 different	 groups	was	 performed	 by	 using	 the	






disease	 results,	 60	 patients	 were	 selected	 in	 order	 to	 perform	 a	 second	
perspective	phase	of	the	research.	The	goal	was	again	to	evaluate	the	role	of	oral	
Hp	 (present	 in	 oral	 cavity),	 in	 gastric	 primary	 infection	 and	 gastric	 reinfection	










maximum	 of	 2	 years)	 from	 the	 phase	 1	 analysis.	 Data	 concerning	 medical	
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therapies,	 previous	 BT	 result,	 pharmacological	 therapies,	 gastrointestinal	






























(time	 0)	 ,	 42	 were	 found	 with	 a	 positive	 result	 (group	 A)	 and	 60	 who	 were	
negative	(group	B).	
Ages	registered	assessed	between	16	and	78,	with	mean	age	of	52	years.	


























Avarage	 time	since	 the	 last	oral	professional	hygiene	was	estimated	14	months,	
with	a	minimum	value	of	1	month	and	a	value	of	maximum	of	120	months.		
Further	 data	 regarded	 previous	 experience	 of	 infection	 by	 Helicobacter	 pylori,	
previous	eradication	treatment	and	the	presence	of	gastrointestinal	symptoms	at	
the	moment	of	the	first	sampling.	
































































































contingency table PREGHP*BTZERO 




 ,00 22 18 40 
 1,00 38 24 62 
TOTAL  60 42 102 
	
chi-square PREGHP*BTZERO 






Pearson’s Chi-square 0,397a 1 ,529   
Continuity correction 0,180 1            ,671   
Likelihood ratio 0,396 1 ,529   
Fisher exact test    ,544 ,335 
Lin-lin association 0,393 1 ,531   


















1	 -	Microbiological	 Analysis	 -	 Breath	 Test,	 Salivary	 and	 Periodontal	 analysis:	 the	
aim	 was	 to	 compare	 the	 bacterial	 load	 of	 Hp	 in	 the	 oral	 cavity,	 saliva	 and	
crevicular	 fluid	 (samples	 collected	 at	 time	0)	 in	 those	patients	 	with	 a	 negative	
history	of	gastric	Hp	infection.	
Firstly	 the	 presence	 of	 Helicobacter	 pylori	 in	 saliva	 was	 evaluated	 in	 all	 102	
patients:	results	ranged	from	0	to	103	HP	units	(average	11	U).	In	particular	67	of	
these	 had	 less	 than	 	 10	U	 and	were	 classified	 as	 negative,	while	 35,	with	more	
than	10	U,	were	considered	positive.	
Then	T-Student	test	was	performed	comparing	the	prescence	of	Hp	in	saliva	
(detected	 at	 time	 0)	 and	 the	 results	 of	 the	 BT	 (performed	 at	 time	 0),	 in	 alpha	
group	(those	patient	without	a	medical	history	for	Hp	infection).	
T-student independent variable BT and HPSALIVA Time 0 
 BTZERO N Mean St deviation St error mean 
HPSALIV
AZERO 
NEG 22 11,3182 18,31311 3,90437 
POS 18 10,2222 17,76499 4,18725 
	
 Levene’s Test T-test 































The	 result	 is	 P=0.850,	 so	 there	 is	 no	 statistically	 significant	 difference	 between	
the	 salivary	 load	 of	 Helicobacter	 pylori	 and	 the	 Breath	 Test	 results	 in	 patients	
with	a	negative	medical	history	for	Hp	infection.	
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In	 order	 to	 confirm	 this	 data,	 a	 Chi-Square	 test	 has	 been	 performed	 (this	 test	
represents	a		qualitative		analysis):	
contingency table ORALSALIVAPOSNEG*BTZERO 





 ,00 14 13 27 
 1,00 8 5 13 















The	 same	 analysis	 was	 performed	 on	 crevicular	 fluid	 samples,	 collected	 from	
periodontal	pockets:	
T-student independent variable BT and HPMEAN Time 0 
 BTZERO N Mean St deviation St error mean 
HPMEAN
ZERO 
NEG 22 31,5455 43,25641 9,22230 
POS 18 15,3889 24,69375 5,82037 
	
 Levene’s Test T-test 
chi-square ORALSALIVAPOSNEG *BTZERO 






Pearson’s Chi-square 0,333a 1 ,564   
Continuity correction ,056 1 ,812   
Likelihood ratio ,335 1 ,563   
Fisher exact test    ,737 ,408 
Lin-lin association ,324 1 ,569   
Valid cases 40     
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contingency table ORALPAROPOSNEG*BTZERO 






 ,00 8 11 19 
 1,00 14 7 21 









chi-square ORALPAROPOSNEG *BTZERO 






Pearson’s Chi-square 2,431a 1 ,119   
Continuity correction 1,540 1 ,215   
Likelihood ratio 2,454 1 ,117   
Fisher exact test    ,203 ,107 
Lin-lin association 2,371 1 ,124   
Valid cases 40     
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contingency table PERIO*BTZERO 
 BTZERO Total 
,00 1,00 
PERIO 
 ,00 15 8 23 
 1,00 7 10 17 





















Pearson’s Chi-square 2,283a 1 ,131   
Continuity correction 1,415 1 ,234   
Likelihood ratio 2,296 1 ,130   
Fisher exact test    ,200 ,117 
Lin-lin association 2,226 1 ,136   




contingency table MPMAX*BTZERO 




 ,00 8 4 12 
 1,00 14 14 28 






























Pearson’s Chi-square ,943 1 ,332   
Continuity correction ,390 1 ,533   
Likelihood ratio ,959 1 ,328   
Fisher exact test    ,491 ,268 
Lin-lin association ,919 1 ,338   
Valid cases 40     
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contingency table SYMPTOMS*BTZERO 




 ,00 0 5 5 
 1,00 22 13 35 
























 chi-square SYMPTOMS *BTZERO 






Pearson’s Chi-square 6,984 1 ,008   
Continuity correction 4,675 1 ,031   
Likelihood ratio 8,871 1 ,003   
Fisher exact test    ,013 ,013 
Lin-lin association 6,810 1 ,009   










infection	 with	 H.pylori.	 All	 of	 them	 were	 treated	 with	 eratication	 therapy,	
however	only	38	resulted	negative	to	BT	at	time	0	while	24	were	positive.	
Similarly	 to	 the	 apha	 group,	 a	 statistical	 analysis	was	 performed	 in	 beta	 group	







T-student independent variable BT and HPMEAN Time 0 
 BTZERO N Mean St deviation St error mean 
HPMEAN
ZERO 
NEG 38 31,0526 59,87281 9,71265 
POS 18 33,6667 113,93693 23,25728 
	
	
 Levene’s Test T-test 















































contingency table ORALPAROPOSNEG*BTZERO 






 ,00 16 17 33 
 1,00 22 7 29 















chi-square ORALPAROPOSNEG *BTZERO 






Pearson’s Chi-square 4,876a 1 ,027   
Continuity correction 3,791 1 ,052   
Likelihood ratio 4,990 1 ,026   
Fisher exact test    ,037 ,025 
Lin-lin association 4,798 1 ,028   

























time	 0	 	 with	 the	 current	 periodontal	 condition,	 without	 considering	 patients’	
history	of	previous	infection.	
	








- Smoking	 habits:	 chi-square	 test	 was	 conducted	 to	 exclude	 the	 role	 of	
smoking	habits	in	BT	results.		A	value	of	P=0,199	confirmed	the	absence	of	
such	a	correlation.	
- Professional	 oral	 hygene	 procedures:	 T-Student	 test	 was	 conducted	 to	
exclude	 the	 role	 of	 Professional	 oral	 hygene	 procedures	 in	 BT	 results;	 in	
particular	BT	data	were	 compared	with	number	of	months	 	 elapsed	 from	
the	 last	oral	hygene.	 	A	value	of	P=0,798	confirmed	 the	absence	of	 such	a	
correlation.	
- Home	oral	hygene	proedures:	T-Student	test	was	conducted	to	exclude	the	
role	 of	 Home	 oral	 hygene	 procedures	 in	 BT	 results.	 	 A	 value	 of	 P=0,985	
confirmed	the	absence	of	such	a	correlation.	
- Previous	 BT:	 chi-square	 test	 was	 conducted	 to	 evaluate	 a	 correlation	
between	results	of	BT	performed	at	time	-1	with	those	of	BT	performed	at	
time	0.	A	value	of	P=0,529	confirmed	the	absence	of	such	a	correlation.	
- Gastrointestinal	 symptoms:	 chi-square	 test	 was	 conducted	 to	 evaluate	 a	
correlation	 between	 gastrointestinal	 symptoms,	 reported	 by	 the	 patients,	






contingency table SYMPTOMS*BTZERO 





 ,00 5 9 14 
 1,00 55 33 88 

























T-student independent variable BT and HPSALIVA Time 0 
 BTZERO N Mean St deviation St error mean 
chi-square SYMPTOMS *BTZERO 






Pearson’s Chi-square 3,578 1 ,059   
Continuity correction 2,557 1 ,110   
Likelihood ratio 3,525 1 ,060   
Fisher exact test    ,080 ,056 
Lin-lin association 3,543 1 ,060   




NEG 60 11,8500 18,62095 2,40395 
POS 42 10,0476 18,01348 2,77954 
	
 Levene’s Test T-test 



































contingency table ORALSALIVAPOSNEG*BTZERO 





 ,00 37 30 67 
 1,00 23 12 35 
TOTAL  60 42 102 
chi-square ORALSALIVAPOSNEG *BTZERO 






Pearson’s Chi-square 1,045a 1 ,307   
Continuity correction ,656 1 ,418   
Likelihood ratio 1,056 1 ,304   
Fisher exact test    ,397 ,209 










The	 same	 analysis	 was	 performed	 on	 crevicular	 fluid	 samples,	 collected	 from	
periodontal	pockets.	
T-student	 test,	 with	 a	 P=0,701,	 showed	 that	 there	 is	 no	 statistically	 significant	
difference	 between	 the	 periodontal	 load	 of	 Helicobacter	 pylori	 and	 the	 Breath	
Test	performed	at	time	0	in	all	patients.	




















In	 this	 further	 statistical	 analysis	 the	 goal	 was	 to	 evaluate	 the	 relationship	
between	 periodontal	 conditions	 and	 the	 oral	 load	 of	 H.pylori,	 particularly	
referring	 to	 pocket	 depth.	 First	 of	 all,	 a	 statistical	 comparison	 (t-student)	 was	




periodontal	 disease	 19	 resulted	 positive	 for	 periodontal	 Hp	 infection	 (14	were	








N Mean St deviation St error mean 
HPMEAN
ZERO 
NEG 69 17,2754 33,33162 4,012265 
POS 33 53,5455 108,98942 18,97262 
	
	
 Levene’s Test T-test 

































































T-student independent variable Time 0 
 MPMAX N Mean St deviation St error mean 
HPMEAN
ZERO 
NEG 29 8,8621 8,30544 1,54228 
POS 73 37,0137 80,50647 9,42257 
	
	
 Levene’s Test T-test 
























































N Mean St deviation St error mean 
HPSALIV
AZERO 
NEG 52 4,7500 7,79360 1,08078 
POS 50 17,7200 23,23618 3,28609 
 Levene’s Test T-test 









































The	result	was	P=0.000.	So	the	higher	 is	 the	bacterial	 load	 in	periodontum	 ,	 the	





contingency table ORALSALIVAPOSNEG*ORALPAROPOSNEG 





 ,00 42 25 67 
 1,00 10 25 35 
















At	 the	 moment	 17	 patients	 has	 been	 recalled	 and	 divided	 into	 the	 groups:	 11	
patients	(4	males	and	7	females)	were	inserted	in	Group	2		(BT	negative	and	Oral	
chi-square ORALSALIVAPOSNEG * ORALPAROPOSNEG 






Pearson’s Chi-square 10,707 1 ,001   
Continuity correction 9,385 1 ,002   
Likelihood ratio 10,963 1 ,001   
Fisher exact test    ,002 ,001 
Lin-lin association 10,602 1 ,001   
Valid cases 102     
	 153	




The	 average	 age	of	 group	1	 is	51	years,	while	 the	 avergae	 age	of	 group	2	 is	59	
years.	













contingency table SALIVAPOSNEGUNO*PAROPOSNEG 





 ,00 7 4 11 
 1,00 0 6 6 
TOTAL  7 10 17 
 






Pearson’s Chi-square 6,491 1 ,011   






















This	 study	 represents	 a	 preliminary	 approach	 on	 the	 role	 of	 oral	Helicobacter	
pylori	(present	in	saliva	and	periodontal	pockets)	in	gastric	infection.	
The	 real	 problem	 with	 this	 infection	 is	 the	 high	 rate	 of	 relapse,	 despite	




The	 oral	 cavity	 could	 represents	 a	 reservoir	 of	 the	 bacterium,	 providing	 an	
optimal	 environment	 for	 its	 proliferation	 and	 protection	 against	 specific	
antibiotic	therapies.	
This	 study	 was	 conducted	 in	 order	 to	 evaluate	 the	 role	 of	 H.pylori	 in	 the	 oral	
cavity	and	its	relationship	with	gastric	infection	recurrence.	
The	study	was	structured	in	two	phases	of	research,	one	descriptive	(Phase	1)	
Likelihood ratio 8,614 1 ,003   
Fisher exact test    ,035 ,017 
Lin-lin association 6,109 1 ,013   










- time	1,	which	corresponds	 to	 the	prospective	phase	of	 the	study:	selected	















24	 remained	 positive	 despite	 the	 eradication	 therapy.	 The	 infection	 rate	 is	
38,71%	in	the	first	group	and	45%	in	the	other.	It	was	possibile	to	verify	that	the	
current	 BT	 result	 (time	 0)	 is	 not	 conditioned	 by	 the	 prior	 infection	 with	 Hp	
(P=0,529).	
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The	 objective	 of	 the	 preliminary	 phase	 of	 the	 study	 is	 to	 find	 out	 if	 there	 is	 a	




in	 the	 saliva	 (P=0.650,	 P=0.409),	 the	 presence	 of	 Hp	 in	 the	 periodontium	 (T-
student	 P=0.906),	 the	 presence	 of	 periodontal	 disease	 (pockets	 >/=	 4mm,	 MP	
mean	P=0.191,	MP	max	P=0.806)	and	the	anamnestic	components	(sex	P=0.126	
and	 smoking	 P=0.550).	 Actually,	 to	 be	 precise,	 one	 difference	was	 found	 (	 Chi-
Square	test),	between	BT	and	the	presence	of	Hp	in	the	periodontium	(P=0,027)	
but	 this	 results	 has	 an	 inverse	 meaning:	 patients	 with	 positive	 Hp	 loads	 in	
periodontum	showed	a	negative	BT	result	at	time	0.	The	meaning	of	this	data	has	
to	 be	 investigated	 in	 the	perspective	 phase	 of	 the	 study,	 in	 order	 to	 clarify	 if	 it	
may	be	due	to	chance	or	the	oral	presence	of	bacterium	can	play	a	preventive	role	
against	gastric	reinfection.	
In	 the	 group	 of	 the	 40	 patients	 with	 a	 negative	 history	 of	 Hp	 infection	 (alpha	
group)	 ,	 22	 remained	 negative	 and	 18	 became	 positive,	 according	 to	 BT	
performed	at	time	0.	
In	 this	 group	 there	were	 no	 significant	 differences	 between	 BT	 results	 and	 the	
presence	of	Hp	 in	 the	 saliva	 (P=0.850,	P=0.564),	 in	 the	periodontium	 (P=0,168,	
P=0,119),	 the	 presence	 of	 periodontal	 disease	 (pockets	 >/=	 4mm,	 MP	 mean	










The	 most	 intresting	 conclusions	 of	 this	 part	 of	 the	 analysis	 concerned	
gastrointestinal	symptoms	reported	by	patients.	
Considering	all	102	patients,	it	emerges	that	there	is	a	correspondence	(although	
not	 completely	 significant:	 P=0.059,	 this	 value	 is	 near	 to	 0,05	 cut	 off)	 between	
symptoms	 reported	 and	 clinical	 situation.	 However	 the	 symptoms	 become	
completely	 reliable	 (P=0.008)	 in	 patients	 with	 negative	 history	 of	 Hp	 infection	
and	 current	 positive	 BT	 (BT-1	 negative	 and	 BT	 0	 positive);	 on	 the	 contrary	 a	
value	of	P=0.702resulted	in	patients	positive	both	at	UBT	at	time	-1	and	at	time	0.	
So	symptoms	are	useful	for	diagnostic	purposes	only	in	patients	who	developed	a	
infection	 for	 the	 first	 time,	 passing	 from	 a	 situation	 of	 health	 to	 one	 of	 disease	
(from	BT-1	negative	 to	BT0	positive):	before	 the	symptom	was	not	present	and	
then	appears,	therefore	it	corresponds	to	the	clinical	reality.	
On	 the	 other	 hand,	 the	 symptoms	 have	 no	meaning	 in	monitoring	 the	 therapy	
against	the	Hp,	because	patients	with	a	positive	history	for	gastric	infection,	who	
managed	 to	 eradicate	 the	 infection,	 sometimes	 keep	 on	 beeing	 symptomatic	 ,		
even	though	the	infection	is	absent.		














(P=0,125)	 ,sex	 (P=0,798),	 smoking	 habits	 (P=0,199),	 drugs	 (exclusion	 criteria),		






	(T-student	 P=0.701).	 However,	 similarly	 to	 time	 -1	 analysys,	 a	 significant	
correlation	(according	to	Chi-square:	P=0,008)	between	Hp	loads	in	periodontum	
and	 BT	 results	 at	 time	 0	 is	 confirmed.	 This	 significance,	 in	 reverse	 relation,	
between	 periodontal	 infection	 by	 Hp	 and	 gastric	 infection	 could	 be	 again	




It	 should	 be	 considered	 that	 Urea	 Breath	 test	 and	 PCR-RT	 are	 two	 different	
methods	of	bacterial	detection,	with	differents	specificity	and	sensitivity.	
The	UBT	measures	of	 the	urease	activity	 and	discriminates	 among	positive	 and	




For	 this	 reason	 a	 less	 invasive,	 but	 equally	 effective,	 diagnostic	 examination	 as	
UBT	it	 is	preferred	for	the	diagnosis	and	follw-up	of	gastric	 infection,	but	 in	the	








periodontal	 pockets	 depth	 values	 of	 all	 102	 patients,	 was	 compared	 with	 UBT	
results	 at	 time	 0,	 in	 order	 to	 	 evaluate	 whether	 the	 presence	 of	 periodontal	
disease	 (average	 or	maximum	 pocket	 depth	 >/=	 4mm)	may	 play	 a	 key	 role	 in	
gastric	infection.	
The	 comparison	between	UBT	 results	 and	periodontal	 disease	does	not	 show	a	











Finally	 it	was	found	that	the	 load	of	Hp	in	saliva	 increases	proportionally	to	the	
periodontal	 load	(t-student,	P=0.000);	a	confirmation	came	form	chi-sqaure	 test	
performed	comparing	Hp	loads	in	saliva	and	crevicular	fluid	(P=0,001).	
In	 the	 pockets,	 the	 bacterium	 can	 proliferate	 in	 favourable	 conditions,	 slipping	
away	from	human	immune	system	surveillance;	once	a	periodontal	reservoir	has	













condition	 to	 a	 prospective	 one,	 aiming	 again	 to	 evaluate	 the	 role	 of	 H.pylori	 in	
gastric	 reinfections	 and	 trying	 to	 find	out	 if	 oral	hygene	procedures	 can	 reduce	
the	relapse	retes.	
If	patients	with	gastric	recurrence	can	be	statistically	associated	with	an	increase	




then	crevicular	 fluid	was	 chosen	as	 fundamental	parameter	 to	be	 considered	 in	
the	 choice	 of	 recruited	 patients,	 since	 it	 is	 exacty	 this	 fluid	 that	 can	 reach	 the	
stomach	 by	 swallowing,	 causing	 a	 possible	 relapse	 of	 the	 disease;	 in	 addition	
peridodontal	 Hp	 load	 has	 been	 demostrated	 to	 be	 proportional	 to	 salivary	 Hp	
load	in	the	“time	0	analysis”.		
So,	 on	 the	 base	 of	 these	 data,	 patients	 were	 divided	 into	 two	 groups:	 group	 1	
included	23	patients	with	negative	UBT	(time	0)	and	positive	Hp	 loads	 in	saliva	
examination	 (performed	 at	 time	 0);	 group	 2	 (the	 Control	 Group)	 involves	 37	




(time	1)	and	a	new	collection	of	oral	 fluids	samples	 	 (both	saliva	and	crevicular	
fluida	at	 time	1).	Minimum	time	between	phase	1	and	2	 is	6	months.	Currently,	





important	paramter	 in	order	 to	understand	 if	 this	procedure	can	reduce	gastric	
recurrence	 rates	by	 eliminating	 the	oral	 reservoir	of	 the	bacterium.	The	 results	
could	be	compared	with	Butt	and	Kahan	anlysis.[97]	
If	 gastric	 recrudescence	was	 reduced	 by	 a	 proper	 periodontal	 therapy	 (scaling,	
rooth	 planing,	 etc.),	 then	 these	 oral	 procedures	 could	 be	 associated	 with	
conventional	 antimicrobial	 theraphy	 in	 order	 to	 increase	 its	 effectiveness	 by	

























the	oral	 cavity	and	 is	not	 related	 to	gastro-esophageal	 reflux,	 like	some	authors	
adfirmed	 in	 the	 literature.	 In	 addition	 to	 gastric	 mucosa,	 this	 bacterium	 can	
colonize	 oral	 periodontum,	 expecially	 in	 patients	 suffering	 from	 periodontal	




the	 stomach	 during	 swallowing.	 Further	 anaysis	 in	 patients	 suffering	 from	 this	
oral	disease	but	negative	at	 gastric	Urea-Breath	Test,	 started	 in	 the	perspective	
phase	 of	 the	 current	 research,	 may	 lead	 to	 the	 discovery	 of	 a	 direct	 causal	
relationship	between	oral	microbiota	and	gastric	infection	recurrence	and	to	the	
evaluation	 of	 the	 role	 of	 	 preventive	 oral	 hygene	 procedures	 .	 From	 this	
perspective	 the	 manteinance	 of	 oral	 health	 and	 professional	 oral	 hygene	
procedures,	 combinable	 with	 standard	 eradication	 protocols,	 acquire	 greater	



















Our	 results	 suggest	 that	 oral	 microbiota	 could	 paly	 an	 important	 role	 in	
gastrointestinal	 diseases	 like	 colorectal	 cancer	 and	 Helicobacter	 pylory	 gastric	
infection.		
Some	 oral	 bacteria	 have	 developed	 the	 ability	 to	 escape	 the	 host	 immune	
surveillance	and	to	induce	inflammatory	responses	leading	to	dangerous	systemic	
effects.		
Periodontitis	 represents	 a	 wide-spread	 common	 disease,	 caused	 by	 dangerous	
bacteria	 like	Fusobacterium	nucleatum	and	Helicobacter	pylori,	detected	in	high	
loads	in	pathological	gums	of	affected	patients.	This	conditions	is	charachterzied	
by	 the	presence	of	periodontal	pockets,	which	 represent	a	natural	 reservoir	 for	
these	 microrganism,	 where	 they	 can	 replicate	 away	 from	 immune	 system,	 be	
poured	into	saliva	and	finally	reach	the	stomach	and	the	intestine	by	swallowing.	
Thus	the	manteinance	of	good	oral	hygiene	could	be	essential	to	prevent	bacterial	
dissemination	 and	 profoessional	 oral	 procedures	 should	 be	 associated	 to	
standard	 medical	 protocols,	 in	 order	 to	 reduce	 risk	 of	 developing	 dangerous	
extra-oral	diseases.	
Further	 studies	 are	 needed	 to	 elucidate	 the	 specific	 role	 of	 these	 bacteria	 in	
systemic	health,	 in	 fact	new	virulence	mechanisms	and	components	continue	 to	
emerge,	even	from	well-known	oral	bacteria.	Only	when	a	clear	understanding	of	
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